Ads
related to: pfizer sec 10 k- COVID Vaccination Finder
Search by City, State, and Zip Code
Find Your Nearest Vaccination Site
- Long COVID information
More Information About Long COVID
Explore Resources and Learn More
- Stay Updated
Learn More About COVID-19
With Our Vaccine Resources
- Your Questions Answered
Find Answers On Our FAQs
Stay Informed About COVID Vaccines
- COVID Vaccination Finder
insights.pfizer.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
A Form 10-K is an annual report required by the U.S. Securities and Exchange Commission (SEC), that gives a comprehensive summary of a company's financial performance. . Although similarly named, the annual report on Form 10-K is distinct from the often glossy "annual report to shareholders", which a company must send to its shareholders when it holds an annual meeting to elect directors ...
Image source: The Motley Fool. Pfizer (NYSE: PFE) Q3 2024 Earnings Call Oct 29, 2024, 10:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call ...
NEW YORK (Reuters) -A federal judge on Tuesday rejected Pfizer's bid to recoup about $75.2 million left over from a U.S. Securities and Exchange Commission insider trading settlement with ...
The settlement amount includes both the civil (False Claims Act) settlement and criminal fine. Glaxo's $3 billion settlement included the largest civil False Claims Act settlement on record, [1] and Pfizer’s $2.3 billion ($3.5 billion in 2022) settlement including a record-breaking $1.3 billion criminal fine. [2]
Initial general form for registration of a class of securities pursuant to section 12(g) (and amendment thereto) 10-D, 10-D/A Periodic distribution reports by Asset-Backed issuers pursuant to Rule 13a-17 or 15d-17 (and amendment thereto) 10-K, 10-K/A Annual report pursuant to section 13 and 15(d) (and amendment thereto) 10-KT, 10-KT/A
The US Securities and Exchange Commission on Thursday charged a former Pfizer employee and his friend for trading on insider information regarding the success of the company’s trial for Paxlovid ...
Before being acquired by Pfizer, it was the world's 39th largest pharmaceutical company. [ 1 ] [ 2 ] On October 12, 2010, King was acquired by Pfizer for $14.25 per share. [ 3 ] King produced a wide range of pharmaceuticals , including Altace for heart attack prevention, Levoxyl for hypothyroidism , Sonata , a sleeping aid , and Skelaxin , a ...
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
Ad
related to: pfizer sec 10 k